Common chromosomal fragile site FRA16D mutation in cancer cells

Human Molecular Genetics

Volumn 14, Issue 10, 2005, Pages 1341-1349

  Finnis, Merran ^a,b   Dayan, Sonia ^a,b   Hobson, Lynne ^a,b   Chenevix Trench, Georgia ^c   Friend, Kathryn ^b   Ried, Karin ^b   Venter, Deon ^d   Woollatt, Erica ^b   Baker, Elizabeth ^a,e   Richards, Robert I ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ARTICLE; AT RICH SEQUENCE; CANCER; CANCER CELL CULTURE; CHROMOSOME FRAGILE SITE; CHROMOSOME FRAGILITY; COLON CARCINOMA; DINUCLEOTIDE REPEAT; DNA SEQUENCE; GENE DELETION; GENE MUTATION; GENETIC SCREENING; HOMOZYGOSITY; HUMAN; HUMAN CELL; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

BASE SEQUENCE; CHROMOSOME DELETION; CHROMOSOME FRAGILE SITES; CHROMOSOMES, HUMAN, PAIR 16; CYTOGENETIC ANALYSIS; HUMANS; LOSS OF HETEROZYGOSITY; MOLECULAR SEQUENCE DATA; NEOPLASMS; REPETITIVE SEQUENCES, NUCLEIC ACID; TUMOR CELLS, CULTURED;

EID: 21144469953     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi144     Document Type: Article

References (36)

1. Richards, R.I. (2001) Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet., 17, 339-345.
2. Richards, R.I. and Sutherland, G.R. (1997) Dynamic mutation: possible mechanism and significance in human disease. Trends Biochem. Sci., 22, 432-436.
3. Sarafidou, T., Kahl, C., Martinez-Garay, I., Mangelsdorf, M., Gesk, S., Baker, E., Kokkinaki, M., Talley, P., Maltby, E.L., French, L. et al. (2004) Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1, encoding a nuclear protein. Genomics, 84, 69-81.
4. Casper, A.M., Nghiem, P., Arlt, M.F. and Glover, T.W. (2002) ATR regulates fragile site stability. Cell, 111, 779-789.
5. Arlt, M.F., Xu, B., Durkin, S.G., Casper, A.M., Kastan, M.B. and Glover, T.W. (2004) BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function. Mol. Cell. Biol., 24, 6701-6709.
6. Musio, A., Montagna, C., Mariani, T., Tilenni, M., Focarelli, M.L., Brait, L., Indino, E., Benedetti, P.A., Chessa, L., Albertini, A., Ried, T. and Vezzoni, P. (2005) SMC involvement in fragile site expression. Hum. Mol. Genet., 14, 525-533.
7. Howlett N.G., Taniguchi T., Durkin S.G. and D'Andrea A Glover T.W. (2005) The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Genet., 14, 693-701.
8. Mishmar, D., Rahat, A., Scherer, S.W., Nyakatura, G., Hinzman, B., Kowi, Y., Mandel-Gutfroind, Y., Lee, J.R., Drescher, B., Sas, D.E. et al. (1998) Molecular characterisation of a common fragile site (FRA7H) on human chromosome 7 by the cloning of an SV40 integration site. Proc. Natl Acad. Sci. USA, 95, 8141-8146.
9. Ried, K., Finnis, M., Hobson, L., Mangelsdorf, M., Dayan, S., Nancarrow, J.K., Woollatt, E., Kremmidiotis, G., Gardner, A., Venter, D., Baker, E. and Richards, R.I. (2000) Common chromosomal fragile site FRA16D DNA sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum. Mol. Genet., 9, 1651-1663.
10. Yunis, J.J. and Soreng, A.L. (1984) Constitutive fragile sites and cancer. Science, 226, 1199-1204.
11. Sutherland, G.R. and Baker, E. (2000) The clinical significance of fragile sites on human chromosomes. Clin. Genet., 58, 157-161.
12. Jones, C., Slijepcevic, P., Marsh, S., Baker, E., Langdon, W.Y., Richards, R.I. and Tunnacliffe, A. (1994) Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum. Mol. Genet., 3, 2123-2130.
13. Jones, C., Penny, L., Mattina, T., Yu, S., Baker, E., Voullaire, L., Langdon, W.Y., Sutherland, G.R., Richards, R.I. and Tunnacliffe, A. (1995) Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature, 376, 145-149.
14. Auer, R.L., Jones, C., Mullenbach, R.A., Syndercombe-Court, D., Milligan, D.W., Fegan, C.D. and Cotter, F.E. (2001) Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia. Blood, 97, 509-515.
15. Huebner K. and Croce C.M. (2002) FRA3B and other common fragile sites: the weakest links. Nat. Rev. Cancer, 1, 214-221.
16. Ohta, M., Inoue, H., Cotticelli, M.G., Kastury, K., Baffa, R., Palazzo, J., Siprashvilli, Z., Mori, M., McCue, P., Druck, T., Croce, C.M. and Huebner, K. (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84, 587-597.
17. Huebner, K., Garrison, P.N., Barnes, L.D. and Croce, C.M. (1998) The role of the FHIT/FRA3B locus in cancer. Ann. Rev. Genet., 32, 7-31.
18. Fong, L.Y.Y., Fidanza, V., Zanesi, N., Lock, L.F., Siracusa, L.D., Mancini, R., Siprashvili, Z., Ottey, M., Martin, S.E., Druck, T. et al. (2000) Muir - Torre-like syndrome in Fhit-deficient mice. Proc. Natl Acad. Sci. USA, 97, 4742-4747.
19. Dumon, K.R., Ishii, H., Fong, L.Y., Zanesi, N., Fidanza, V., Mancini, R., Vecchione, A., Baffa, R., Trapasso, F., During, M.J., Huebner, K. and Croce, C.M. (2001) FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc. Natl Acad. Sci. USA, 98, 3346-3351.
20. Mangelsdorf, M., Ried, K., Woollatt, E., Dayan, S., Eyre, H., Finnis, M., Hobson, L., Nancarrow, J., Venter, D., Baker, E. and Richards, R.I. (2000) Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res., 60, 1683-1689.
21. Paige, A.J.W., Taylor, K.J., Stewart, A., Sgouros, J., Gabra, H., Smyth, J.F., Porteous, D.J.and Watson, J.E.V. (2000) A 700 kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res., 60, 1690-1696.
22. Bednarek, A.K., Laflin, K.J., Daniel, R.L., Liao, Q., Hawkins, K.A. and Aldaz, C.M. (2000) WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res., 60, 2140-2145.
23. Chang, N.S., Pratt, N., Heath, J., Schultz, L., Sleve, D., Carey, G.B. and Zevotek, N. (2001) Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J. Biol. Chem., 276, 3361-3370.
24. Chang N.S., Doherty J., Ensign A., Lewis J., Heath J., Schultz L., Chen S.T. and Oppermann U. (2003) Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses. Biochem. Pharmacol., 66, 1347-1354.
25. Chesi, M., Bergsagel, P.L., Shonukan, O.O., Martelli, M.L., Brents, L.A., Chen, T., Schrok, E., Ried, T. and Kuehl, W.M. (1998) Frequent dysregulation of the c-MAF proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood, 91, 4457-4463.
26. Krummel, K.A., Denison, S.R., Calhoun, E., Phillips, L.A. and Smith, D.I. (2002) The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1. Genes Chrom. Cancer., 34, 154-167.
27. Bednarek, A.K., Keck-Waggoner, C.L., Daniel, R.L., Laflin, K.J., Bergsagel, P.L., Kiguchi, K., Brenner, A.J. and Aldaz, C.M. (2001) WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res., 61, 8068-8073.
28. Driouch, K., Prydz, H., Monese, R., Johansen, H., Lidereau, R. and Frengen, E. (2002) Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene, 21, 1832-1840.
29. Morikawa, K., Walker, S.M., Nakajima, M., Pathak, S., Jessup, J.M. and Fidler, I.J. (1988) Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res., 48, 6863-6871.
30. Latil, A., Cussenot, O., Fournier, G., Driouch, K. and Lidereau, R. (1997) Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independant regions. Cancer Res., 57, 1058-1062.
31. Driouch, K., Dorion-Bonnet, F., Briffod, M., Champeme, M.H., Longy, M. and Lidereau, R. (1997) Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chrom. Cancer, 19, 185-191.
32. Zlotorynski E., Rahat A., Skaug J., Ben-Porat N., Ozeri E., Hershberg R., Levi A., Scherer S.W., Margalit H. and Kerem, B. (2003) Molecular basis for expression of common and rare fragile sites. Mol. Cell. Biol., 23, 7143-7151.
33. Corbin, S., Neilly, M.E., Espinosa, R., III, Davis, E.M., McKeithan, T.W. and Le Beau, M.M. (2002) Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Cancer Res., 62, 3477-3484.
34. Rao, P.N., Heerema, N.A. and Palmer, C.G. (1988) Fragile sites induced by FudR, caffeine and aphidicolin. Their frequency, distribution and analysis. Hum. Genet., 78, 21-26.
35. Tunca, B., Egeli, U., Zorluoglu, A., Yilmazlar, T., Yerci, O. and Kizil, A. (2000) The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives. Cancer Lett., 152, 201-209.
36. Arlt, M.F., Miller, D.E., Beer, D.G. and Glover, T.W. (2002) Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chrom. Cancer, 33, 8292.